Psychiatric and Psychological Co-Morbidity in Patients with Dermatologic Disorders: Epidemiology and Management

American Journal of Clinical Dermatology

Volumn 4, Issue 12, 2003, Pages 833-842

  Gupta, Madhulika A ^a,b,d   Gupta, Aditya K ^b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ACNE; ATOPIC DERMATITIS; BODY DYSMORPHIC DISORDER; CARDIOTOXICITY; COMORBIDITY; DISABILITY; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGICAL DATA; FAMILY THERAPY; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; RISK; SECONDARY PREVENTION; SKIN DISEASE; SOCIAL PHOBIA; SOCIAL PSYCHOLOGY; SUICIDE; URTICARIA;

ACNE VULGARIS; COMORBIDITY; DEPRESSIVE DISORDER; DERMATITIS, ATOPIC; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PSORIASIS; PSYCHOTIC DISORDERS; SKIN DISEASES; SOMATOFORM DISORDERS; STRESS, PSYCHOLOGICAL; URTICARIA;

EID: 0346964360     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200304120-00003     Document Type: Review

References (87)

1. Gupta MA, Gupta AK. Psychodermatology: an update. J Am Acad Dermatol 1996; 34: 1030-46
2. Picardi A, Abeni D, Melchi CF, et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-91
3. Medansky RS, Handler RM. Dermatopsychosomatics: classification, physiology, and therapeutic approaches. J Am Acad Dermatol 1981; 5: 125-36
4. Koblenzer CS. Psychosomatic concepts in dermatology. Arch Dermatol 1983; 119: 501-12
5. Panconesi P. Psychosomatic dermatology. Clin Dermatol 1984; 2: 94-179
6. Seville RH. Psoriasis and stress. Br J Dermatol 1977; 97: 297-302
7. Polenghi MM, Molinari E, Gala C, et al. Experience with psoriasis in a psychosomatic dermatology clinic. Acta Derm Venereol (Stockh) 1994; 186: 65-6
8. Nyfors A, Lemholt K. Psoriasis in children. Br J Dermatol 1975; 92: 437-42
9. Al'Abadie MS, Kent GG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994; 130: 199-203
10. Mazzetti M, Mozzetta A, Soavi GC, et al. Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta Derm Venereol (Stockh) 1994; 186: 62-4
11. Gupta MA, Gupta AK, Kirkby S, et al. A psychocutaneous profile of psoriasis patients who are stress reactors: a study of 127 patients. Gen Hosp Psychiatry 1989; 11: 166-73
12. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63
13. Gupta MA, Gupta AK. Quality of life of psoriasis patients. J Eur Acad Derm Venereol 2000 Jul; 14 (4): 267-71
14. Fortune DG, Richards HL, Griffiths CE, et al. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41 (Pt 2): 157-74
15. Gupta MA, Gupta AK, Watteel G. Early onset (
16. Niemeier V, Nippesen M, Kupfer J, et al. Psychological factors associated with hand dermatoses: which subgroup needs additional psychological care? Br J Dermatol 2002; 146: 1031-7
17. Feldman SR, Fleischer Jr AB, Reboussin DM, et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997; 37 (4): 564-9
18. Kirkby B, Richards HL, Woo P, et al. Physical and psychological measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001; 45 (1): 72-6
19. Fortune DG, Main CJ, O'Sullivan TM, et al. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755-60
20. Gupta MA, Gupta AK, Haberman HF. Psoriasis and psychiatry: an update. Gen Hosp Psychiatry 1987; 9: 157-66
21. Fava GA, Perini GI, Santonastaso P, et al. Life events and psychosocial distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. Br J Med Psychol 1980; 53: 277-82
22. Matussek P, Agerer D, Seibt G. Aggression in depressives and psoriatics. Psychother Psychosom 1985; 43: 120-5
23. Arnetz BB, Fjellner B, Eneroth P, et al. Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 1985; 47: 528-41
24. Rubino IA, Sonnino A, Pezzarossa B, et al. Personality disorders and psychiatric symptoms in psoriasis. Psychol Rep 1995; 72: 547-53
25. Vidoni D, Campiutti E, D'Aronco R, et al. Psoriasis and alexithymia. Acta Derm Venereol (Stockh) 1989; 146: 91-2
26. Goldsmith LA, Fisher M, Wacks J. Psychological characteristics of psoriatics. Arch Dermatol 1969; 100: 674-6
27. Gupta MA, Gupta AK, Schork NJ, et al. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994; 56: 36-40
28. Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis: a prospective study of some psychiatric and dermatologic correlates. Arch Dermatol 1988; 124: 1052-7
29. Gupta MA, Gupta AK, Schork NJ, et al. Suicidal ideation in psoriasis. Int J Dermatol 1993; 32: 188-90
30. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139 (5): 846-50
31. Morse RM, Perry HO, Hurt RD. Alcoholism and psoriasis. Alcohol Clin Exp Res 1985; 9: 396-9
32. Mills CM, Srivastava RD, Harvey IM, et al. Smoking habits in psoriasis: a case control study. Br J Dermatol 1992; 127: 18-21
33. Gupta MA, Schork NJ, Gupta AK, et al. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993; 28: 730-2
34. Gupta MA, Gupta AK, Watteel GN. Cigarette smoking in men may be a risk factor for increased severity of psoriasis of the extremities [letter]. Br J Dermatol 1996; 135: 859-60
35. Layton M. Optimal management of acne to prevent scarring and psychological sequelae. Am J Clin Dermatol 2001; 2: 135-41
36. Wu SF, Kinder BN, Trunnell TN, et al. Role of anxiety and anger in acne patients: a relationship with severity of the disorder. J Am Acad Dermatol 1988; 18 (2 Pt 1): 325-33
37. Gupta MA, Gupta AK. The psychological comorbidity in acne. Clin Dermatol 2001; 19: 360-3
38. Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140 (4): 672-6
39. Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community based study. Br J Dermatol 2001; 145 (2): 274-9
40. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol 1997; 137 (2): 246-50
41. Roy A. Suicide. In: Sadock BI, Sadock VA, editors. Kaplan & Sadock's comprehensive textbook of psychiatry. 7th ed on CD-ROM. Folio Infobase. Philadelphia (PA): Lippincott Williams & Wilkins, 2000
42. Gupta MA, Gupta AK, Schork NJ, et al. Psychiatric aspects of the treatment of mild to moderate facial acne: some preliminary observations. Int J Dermatol 1990; 29(10): 719-21
43. Rubinow DR, Peck GL, Squillace KM, et al. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17 (1): 25-32
44. Gupta MA, Johnson AM, Gupta AK. The development of an Acne Quality of Life scale: reliability, validity, and relation to subjective acne severity in mild to moderated acne vulgaris. Acta Derm Venereol 1998; 78 (6): 451-6
45. Layton AM, Seukeran D, Cunliffe WJ. Scarred for life? Dermatology 1997; 195 Suppl. 1: 15-21
46. Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140 (2): 273-82
47. Physicians' Desk Reference. 56th ed. Montvale (NJ): Medical Economics Data Production Company, 2002
48. Gupta MA, Gupta AK. Dermatological complications. Eur Eating Disorders Rev 2000; 8 (2): 134-43
49. Gupta MA, Gupta AK, Haberman HF. Dermatologic signs in anorexia nervosa and bulimia nervosa. Arch Dermatol 1987; 123: 1386-90
50. Sneddon J, Sneddon I. Acne excoriee: a protective device. Clin Exp Dermatol 1983; 8: 65-8
51. Cotterill JA. Dermatologic non-disease: a common and potentially fatal disturbance of cutaneous body image. Br J Dermatol 1981; 104: 611-9
52. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
53. Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation: clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 2001; 15: 351-9
54. Kilpelainen M, Koskenvuo M, Helenius H, et al. Stressful life events promote the manifestation of asthma and atopic diseases. Clin Exp Allergy 2002; 32: 256-63
55. Faulstich ME, Williamson DA. An overview of atopic dermatitis: toward a biobehavioral integration. J Psychosom Res 1985; 29: 415-7
56. Howlett S. Emotional dysfunction, child-family relationships and childhood atopic dermatitis. Br J Dermatol 1999; 140 (3): 381-4
57. Buske-Kirschbaum A, Gierens A, Hollig H, et al. Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol 2002; 129: 161-7
58. Pauli-Pott U, Darui A, Beckmann D. Infants with atopic dermatitis: maternal hopelessness, child-rearing attitudes and perceived infant temperament. Psychother Psychosom 1999; 68: 39-45
59. Kodama A, Horikawa T, Suzuki T, et al. The effect of stress on atopic dermatitis: investigation in patients and the great Hanshin earthquake. J Allergy Clin Immunol 1999; 104 (1): 173-6
60. Buske-Kirschbaum A, Geiben A, Hollig H, et al. Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J Clin Endocrinol Metab 2002; 87: 4245-51
61. Kemp S. Atopic eczema: its social and financial cost. J Pediatr Child Health 1999; 35 (3): 229-31
62. Schmid-Ott G, Kuensebeck HW, Jaeger B, et al. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol 1999; 79(6): 443-7
63. Kiebert G, Sorensen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41: 151-8
64. Absolon CM, Cottrell D, Eldridge SM, et al. Psychological disturbance in atopic eczema: the extent of the problem in school-aged children. Br J Dermatol 1997; 137 (2): 241-5
65. Linnet J, Jemec GB. An assessment of anxiety and dermatology quality of life in patients with atopic dermatitis. Br J Dermatol 1999; 140 (2): 268-72
66. Ginsburg IH, Prystowsky JH, Kornfeld DS, et al. Role of emotional factors in adults with atopic dermatitis. Int J Dermatol 1993; 32: 656-60
67. Scheich G, Florin I, Rudolph R, et al. Personality characteristics and serum IgE level in patients with atopic dermatitis. J Psychosom Res 1993; 37: 637-42
68. Ullman KC, Moore RW, Reidy M. Atopic eczema: a clinical psychiatric study. J Asthma Res 1977; 14: 91-9
69. Koblenzer CS, Koblenzer PJ. Chronic intractable atopic eczema. Arch Dermatol 1988; 124: 1673-7
70. Hashiro M, Okumura M. The relationship between the psychological and immunological in patients with atopic dermatitis. J Dermatol Sci 1998; 16 (3): 231-5
71. Michaelsson G. Chronic urticaria. Acta Derm Venereol (Stockh) 1969; 49: 404-16
72. Stewart JH, Goodman MM. Earthquake urticaria [case report]. Cutis 1989; 43: 340
73. Rees L. An aetiological study of chronic urticaria and angioneurotic oedema. J Psychosom Res 1957; 2: 172-89
74. Juhlin L. Recurrent urticaria: clinical investigations of 330 patients. Br J Dermatol 1981; 104: 369-81
75. Anderson RT, Rajagopalan R. Effects of allergic dermatosis on health-related quality of life. Curr Allergy Asthma Rep 2001; 1: 309-15
76. Poon E, Seed PT, Greaves MW, et al. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999; 140: 667-71
77. Badoux A, Levy DA. Psychologic symptoms in asthma and chronic urticaria. Ann Allergy 1994; 72: 229-34
78. Hashiro M, Okumura M. Anxiety, depression, psychosomatic symptoms and autonomie nervous system function in patients with chronic urticaria. J Dermatol Sci 1994; 8: 129-35
79. Sheehan-Dare RA, Henderson MJ, Cotterill JA. Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol 1990; 123: 769-74
80. Engel GL. The clinical application of the biopsychosocial model. Am J Psychiatry 1980; 137: 535-44
81. Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis upon the quality of life. Int J Dermatol 1995; 34: 700-3
82. Hyman SE. The suicidal patient. In: Hyman SE, Tesar GE, editors. Manual of psychiatric emergencies. 3rd ed. Boston (MA): Little. Brown and Company, 1994: 21-27
83. Koo JYM, Pham CT. Psychodermatology-practical guidelines on pharmacotherapy. Arch Dermatol 1992; 126: 381-8
84. Folks DG, Kinney FC. The role of psychological factors in dermatologie conditions. Psychosomatics 1992; 33: 45-54
85. Gupta MA. Dermatology. In: Stoudemire A, Fogel BS, editors. Psychiatric care of the medical patient. New York: Oxford University Press, 1993: 681-690
86. Gupta MA, Gupta AK. Use of eye movement desensitization and reprocessing (EMDR) in the treatment of dermatologie disorders. J Cutan Med Surg 2002; 6 (5): 415-21
87. Gupta MA, Gupta AK. The use of psychotropic drugs in dermatology. Dermatol Clin 2000 Oct; 18 (4): 711-25